FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for neuroimmune disorder diagnostics associated with epilepsy. Electroencephalographic (EEG) monitoring is performed. Thus EEG is registered on head surface and if slow waves are found in rest state with amplitude 1.5-2.0 times exceeding background values, and alpha activity index is lowered in posterior diversions, as well as alpha index is lowered after functional tests in all hemisphere diversions while it is increased in anterior cerebrum area, neuroimmune disorders are diagnosed for epilepsy patient. Method provides widen range of means for neuroimmune disorders diagnostics associated with epilepsy.
EFFECT: development of new effective method of neuroimmune disorders diagnostics associated with epilepsy.
4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ESTIMATING SEVERITY DEGREE OF EPILEPSY COMPLICATED BY ORGANIC ENCELOPHATHY | 2009 |
|
RU2433784C2 |
| METHOD FOR PREDICTING PRE-CLINICAL STAGE OF EPILEPSY | 2003 |
|
RU2246727C2 |
| METHOD FOR DIAGNOSING THE CASES OF EPILEPSY AND ITS PRELIMINARY STAGE | 1999 |
|
RU2156607C1 |
| METHOD FOR DIAGNOSING NEUROIMMUNE DISORDERS IN YOUNG CHILDREN WITH EPILEPSY | 2021 |
|
RU2767271C1 |
| METHOD FOR PREDICTING THE UNFAVORABLE COURSE OF EPILEPSY IN CHILDREN IN THE FIRST YEAR OF LIFE | 2022 |
|
RU2787512C1 |
| METHOD FOR PREDICTING REMISSION OF EPILEPSY | 2003 |
|
RU2238029C1 |
| METHOD FOR DIAGNOSING AND PREDICTING EPILEPSY DEVELOPMENT IN PATIENTS AT PRECLINICAL DISEASE STAGE | 2001 |
|
RU2189776C1 |
| METHOD OF DIAGNOSING AND TREATING PRECLINICAL EPILEPSY PHASE | 2003 |
|
RU2231363C1 |
| METHOD FOR DIAGNOSTICS AND PREDICTION OF EPILEPSY DEVELOPMENT IN PATIENTS AT PRECLINICAL STAGE OF THE DISEASE | 2001 |
|
RU2188575C1 |
| METHOD FOR PREDICTING DIFFERENT STAGES OF EPILEPTOGENESIS | 2004 |
|
RU2297791C2 |
